S&P places Abbott on watch

Standard & Poor's said it placed its AA/A-1+ long- and short-term ratings on diversified pharmaceutical company Abbott Laboratories on CreditWatch with negative implications.

"The CreditWatch listing reflects the smaller business risk profile and uncertain financial risk profile of the remaining operations at Abbott," said S&P credit analyst David Lugg in a news release.

Precisely which pharmaceuticals will remain with Abbott is uncertain, although the emerging-market focus is clear, the agency said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.